Skip to content

    Recently Viewed


      Headshot Jaszianne Tolbert, MD, Executive Medical Director, Oncology
      Home /

      Our vision: The elimination of cancer

      ‎At Johnson & Johnson, we are driven by our bold vision to eliminate cancer. Together, we work diligently to get in front of cancer and will never settle until the disease is behind everyone.

      Odds are that every person in the world knows, loves or is someone confronting cancer. It is the second leading cause of death globally, often disproportionately impacting people from underrepresented and underserved backgrounds. With its devastating impact on people and families worldwide, immediate action is needed to transform cancer care.

      At Johnson & Johnson, we innovate with purpose to lead where medicine is going. We listen and learn with compassion to understand the needs of patients, caregivers, and healthcare professionals who remind us every day why we are working toward the elimination of cancer. Our aim is to not only take down disease, but to change and save lives. Our aim is to be in front of cancer.
      Mary Guckert, Vice President, Oncology Delivery Unit, Global Development, Johnson & Johnson sitting at a table being interviewed
      Mary Guckert, Vice President, Oncology Delivery Unit, Global Development, Johnson & Johnson sitting at a table being interviewed

      In front of cancer: Mary’s story

      For Mary Guckert, who oversees the strategy and execution of our oncology portfolio, cancer is deeply personal. Her story reminds us of why we will never settle in our pursuit to eliminate this disease.
      A child laughs as he plays with another child and a man on a green lawn
      A child laughs as he plays with another child and a man on a green lawn

      Our bold ambition: To get in front of cancer

      We are working every day to advance the next wave of innovations to change and save lives and be in front of cancer for patients, caregivers, and healthcare professionals.

      Our expertise: Pioneering innovations

      Our expert researchers and integrated oncology teams are taking a holistic approach to tackling some of the most serious forms of cancer across hematologic and solid tumor malignancies – from developing preventative approaches and methods of early interception and detection, to creating new therapies and surgical devices, including breakthrough robotics solutions.
      Scientist examining a sample in a petri dish

      Could we be on our way to eliminating cancer for good?

      What once seemed like an out-of-reach goal may soon be within our grasp. Take an in-depth look at how Johnson & Johnson is working toward its vision of helping create a world without cancer.
      Pipette adding sample to Petri dish for genetic research

      Are super-personalized solutions the future of healthcare?

      The goal of precision medicine is to develop individualized treatments based on a patient’s genetic profile. Here’s how Johnson & Johnson is harnessing this cutting-edge field of tailor-made medicine.
      Researcher using a pipette in the lab

      Behind the relentless pursuit of multiple myeloma cures

      Johnson & Johnson has been dedicated to developing innovative treatments for blood cancers for nearly 20 years. Scientist Kodandaram “Ram” Pillarisetti is at the forefront of the company’s commitment to working toward its goal of one day eliminating the disease.
      Black female scientist with blue gloves looking through a microscope

      How Johnson & Johnson is advancing new options for bladder cancer treatment

      Every year, roughly 80,000 Americans receive a bladder cancer diagnosis. Many endure difficult and burdensome treatments in an attempt to fight the disease. But new innovations just might change that.

      5 things we now know about multiple myeloma

      Rates of this blood cancer have jumped more than 125% worldwide since the 1990s. But there’s reason to have hope: Today, life expectancy has at least doubled in some cases. That’s thanks to increased research, new learnings and innovative advances—and Johnson & Johnson is at the forefront of this crucial work.
      Headshots of Dr. Kallenbach, Dr. Madduri and Dr. Cortoos

      Could these 3 researchers transform the fates of patients with multiple myeloma?

      For National Cancer Prevention Month, we’re spotlighting three leading Johnson & Johnson female hematologists—innovators who are not only saving lives and advancing new treatments but also paving the way for the next generation of women in their field.
      An illustration of microbiomes

      Could changes in your microbiome increase your risk of colorectal cancer?

      That’s exactly what researchers at Johnson & Johnson are trying to find out. By partnering on a new study that’s looking at the role gut microbes may play in the disease—and focusing on the underrepresented groups most affected—they hope to advance early-detection strategies and potential treatments.

      Our inspiration: For us, it’s personal

      Employees across Johnson & Johnson are working tirelessly to get in front of cancer and create a future where cures are a reality and cancer is eradicated. We listen and learn with compassion to understand the needs of patients, who motivate us to define a new way forward.
      Health & wellness
      Husband and wife sitting on couch looking at laptop

      “I’m supporting my husband through cancer treatment”

      When Craig was diagnosed with multiple myeloma, his wife Cara took on a new role: caregiver. For National Caregiver’s Day, she shares the challenges—as well as the triumphs—of this difficult journey.
      Personal stories
      An illustration of a cancerous mass in the lungs

      “No one would believe me when I suspected I had lung cancer”

      Learn about one patient’s journey toward getting an accurate diagnosis—and why it’s crucial to always advocate for your health.
      Health & wellness
      A close-up of two people holding hands

      By the numbers: Helping to reduce disparities in cancer care

      For World Health Day, learn how Johnson & Johnson’s commitment to Diversity, Equity and Inclusion is helping to deliver transformational cancer treatments and solutions that reach the patients who need them most.
      Doctor listening to a little girl's heartbeat with a stethoscope

      “I’m working to develop better treatments for children with devastating diseases”

      A life-threatening condition that afflicts young cancer patients. A rare and painful form of pediatric arthritis. Learn about how Johnson & Johnson is innovating to use existing medications to help kids with these illnesses—and meet two women on the forefront of this game-changing work.
      A group of faces in profile

      What it takes to truly diversify clinical trials

      What do diseases like multiple myeloma and lupus have in common? They’re more prevalent in people of color—yet historically these patients have been left out of clinical research, often to dire health consequences. Learn how Johnson & Johnson is working to make the study of conditions like these more equitable.

      Oncology latest news

      Learn more about the latest oncology news across Johnson & Johnson.
      You are now leaving The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.